Monday, January 10, 2022

Human Trials Now Begin for Preventive Vaccine for Parkinson’s Disease

A new study, led by the Institute for Molecular Medicine (IMM) and the National Institute of Aging in collaboration with the University of California, Irvine, and the University of California, San Diego, describes four vaccines designed to generate high levels of antibodies specific to various regions of pathological α-Synuclein, the protein associated with Parkinson Disease (PD), Dementia with Lewy bodies (DLB), and other synucleinopathies, including Alzheimer's disease (AD). - eTurboNews | Trends | Travel News

No comments:

Post a Comment